Matches in SemOpenAlex for { <https://semopenalex.org/work/W4302014263> ?p ?o ?g. }
- W4302014263 abstract "Abstract Elevated triglycerides and non-HDL-cholesterol (C) are risk factors for atherosclerotic cardiovascular disease (ASCVD). AROANG3 is a RNA interference therapy targeting hepatocyte production of angiopoietin-like protein 3 (ANGPTL3), a regulator of lipoprotein metabolism. This Phase 1 trial (NCT03747224) investigated single and repeat doses of AROANG3 in healthy volunteers and repeat doses in subjects with hepatic steatosis. AROANG3 was well tolerated without adverse changes in liver fat in steatotic subjects. In healthy volunteers, ARO-ANG3 produced reductions in ANGPTL3 (mean − 45% to -78%) 12 weeks post-dose. Concurrent reductions in triglycerides (median 34% to 54%) and nonHDL-C (mean 18% to 29%) were observed with the 3 highest doses. Reduced LDL-C was seen with repeat dosing. The data support ANGPTL3 as a potential therapeutic target for treatment of ASCVD." @default.
- W4302014263 created "2022-10-06" @default.
- W4302014263 creator A5001058333 @default.
- W4302014263 creator A5001549960 @default.
- W4302014263 creator A5002935320 @default.
- W4302014263 creator A5003834872 @default.
- W4302014263 creator A5012038189 @default.
- W4302014263 creator A5020003074 @default.
- W4302014263 creator A5026199172 @default.
- W4302014263 creator A5028045704 @default.
- W4302014263 creator A5052604218 @default.
- W4302014263 creator A5058758956 @default.
- W4302014263 creator A5066507748 @default.
- W4302014263 creator A5070816464 @default.
- W4302014263 creator A5072796310 @default.
- W4302014263 creator A5082366563 @default.
- W4302014263 creator A5083791996 @default.
- W4302014263 creator A5089509231 @default.
- W4302014263 creator A5090781778 @default.
- W4302014263 creator A5091197396 @default.
- W4302014263 date "2022-10-05" @default.
- W4302014263 modified "2023-10-18" @default.
- W4302014263 title "RNA interference targeting hepatic angiopoietin-like protein 3 results in prolonged reductions in serum triglyceride and non-HDL-cholesterol concentrations: first human results with ARO-ANG3" @default.
- W4302014263 cites W1944135887 @default.
- W4302014263 cites W1958022600 @default.
- W4302014263 cites W2103334195 @default.
- W4302014263 cites W2106937178 @default.
- W4302014263 cites W2156718297 @default.
- W4302014263 cites W2604768034 @default.
- W4302014263 cites W2617605538 @default.
- W4302014263 cites W2618984243 @default.
- W4302014263 cites W2757794608 @default.
- W4302014263 cites W2761312904 @default.
- W4302014263 cites W2767569336 @default.
- W4302014263 cites W2949132703 @default.
- W4302014263 cites W2955013370 @default.
- W4302014263 cites W2991262768 @default.
- W4302014263 cites W2999177103 @default.
- W4302014263 cites W3041635484 @default.
- W4302014263 cites W3044543495 @default.
- W4302014263 cites W3061843793 @default.
- W4302014263 cites W3082366829 @default.
- W4302014263 cites W3206727734 @default.
- W4302014263 cites W4229019883 @default.
- W4302014263 cites W4280490948 @default.
- W4302014263 doi "https://doi.org/10.21203/rs.3.rs-2097342/v1" @default.
- W4302014263 hasPublicationYear "2022" @default.
- W4302014263 type Work @default.
- W4302014263 citedByCount "2" @default.
- W4302014263 countsByYear W43020142632023 @default.
- W4302014263 crossrefType "posted-content" @default.
- W4302014263 hasAuthorship W4302014263A5001058333 @default.
- W4302014263 hasAuthorship W4302014263A5001549960 @default.
- W4302014263 hasAuthorship W4302014263A5002935320 @default.
- W4302014263 hasAuthorship W4302014263A5003834872 @default.
- W4302014263 hasAuthorship W4302014263A5012038189 @default.
- W4302014263 hasAuthorship W4302014263A5020003074 @default.
- W4302014263 hasAuthorship W4302014263A5026199172 @default.
- W4302014263 hasAuthorship W4302014263A5028045704 @default.
- W4302014263 hasAuthorship W4302014263A5052604218 @default.
- W4302014263 hasAuthorship W4302014263A5058758956 @default.
- W4302014263 hasAuthorship W4302014263A5066507748 @default.
- W4302014263 hasAuthorship W4302014263A5070816464 @default.
- W4302014263 hasAuthorship W4302014263A5072796310 @default.
- W4302014263 hasAuthorship W4302014263A5082366563 @default.
- W4302014263 hasAuthorship W4302014263A5083791996 @default.
- W4302014263 hasAuthorship W4302014263A5089509231 @default.
- W4302014263 hasAuthorship W4302014263A5090781778 @default.
- W4302014263 hasAuthorship W4302014263A5091197396 @default.
- W4302014263 hasBestOaLocation W43020142631 @default.
- W4302014263 hasConcept C126322002 @default.
- W4302014263 hasConcept C134018914 @default.
- W4302014263 hasConcept C197934379 @default.
- W4302014263 hasConcept C2776175330 @default.
- W4302014263 hasConcept C2778163477 @default.
- W4302014263 hasConcept C2778913445 @default.
- W4302014263 hasConcept C2780072125 @default.
- W4302014263 hasConcept C2780948078 @default.
- W4302014263 hasConcept C43554185 @default.
- W4302014263 hasConcept C71924100 @default.
- W4302014263 hasConceptScore W4302014263C126322002 @default.
- W4302014263 hasConceptScore W4302014263C134018914 @default.
- W4302014263 hasConceptScore W4302014263C197934379 @default.
- W4302014263 hasConceptScore W4302014263C2776175330 @default.
- W4302014263 hasConceptScore W4302014263C2778163477 @default.
- W4302014263 hasConceptScore W4302014263C2778913445 @default.
- W4302014263 hasConceptScore W4302014263C2780072125 @default.
- W4302014263 hasConceptScore W4302014263C2780948078 @default.
- W4302014263 hasConceptScore W4302014263C43554185 @default.
- W4302014263 hasConceptScore W4302014263C71924100 @default.
- W4302014263 hasLocation W43020142631 @default.
- W4302014263 hasOpenAccess W4302014263 @default.
- W4302014263 hasPrimaryLocation W43020142631 @default.
- W4302014263 hasRelatedWork W1976602105 @default.
- W4302014263 hasRelatedWork W2004682325 @default.
- W4302014263 hasRelatedWork W2033921535 @default.
- W4302014263 hasRelatedWork W2035440468 @default.
- W4302014263 hasRelatedWork W2035484352 @default.
- W4302014263 hasRelatedWork W2068768710 @default.
- W4302014263 hasRelatedWork W2072909849 @default.